Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046111 · ClinicalTrials.gov registry record · Phase 1
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00046111 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 1 participants.
The verdict
NCT00046111, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two capsules of topotecan made by slightly different methods. This will be done by giving the drug made by the two different methods to patients orally and testing blood levels.
Interventions
- DRUG topotecan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2001-09 |
| Est. Completion | 2004-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00046111
The ClinicalTrials.gov registry entry for NCT00046111 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which topotecan is the first listed.
NCT00046111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00046111 about?
NCT00046111 is a clinical study titled "A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors". The purpose of this study is to compare two capsules of topotecan made by slightly different methods. This will be done by giving the drug made by the two different methods to patients orally and testing blood levels.
What is the current status of trial NCT00046111?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2001-09. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00046111?
The interventions under investigation include: topotecan (DRUG).
Who is sponsoring clinical trial NCT00046111?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.